First described in 1937 by Turkish dermatologist Hulusi Behçet, Professor Ordinarius, MD, Behçet's disease is a chronic condition that causes oral and genital wounds and ocular inflammation. Behçet's disease is more common in people living at certain latitudes, i.e. on the Silk Road, in Turkey, Mediterranean countries, Israel and Japan.
In addition to these significant symptoms, it may have destructive effects on different organs including major vessels, the central nervous system (brain), joints, the skin, digestive system and the lungs.
Causes of Behçet's Disease
The causes of Behçet's disease are not exactly known. The immune system is compromised and there is inflammation of the vessels. However, the trigger of this reaction is not known. While genetic factors, previous diseases and environmental factors are considered to be responsible, a single cause cannot be pointed.
Treatment of Behçet's Disease
The purpose of treatment in Behçet's disease is to alleviate complaints and prevent blindness. The drug to be used and duration of treatment depends on the patient's condition. Several drugs can be used concomitantly in some cases. Today, vision can be maintained at a high rate of 80% in patients with Behçet's disease.